Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.
Linda Holmstrand ZetterlundF CelebiogluT HatschekJ FrisellJ de BonifacePublished in: The British journal of surgery (2021)
The present findings underline the prognostic significance of nodal status after neoadjuvant systemic therapy. This confirms the clinical value of surgical axillary staging after neoadjuvant systemic therapy.